NBC News @NBCNews
Pfizer provides early glimpse at the findings from their ongoing study in humans, saying in a press release that the updated booster generated a strong immune response against the BA.4 and BA.5 subvariants. https://t.co/yoULeKzt9c — PolitiTweet.org